03:53 PM EST - Theratechnologies : posted a second-quarter loss of $5.43 million or $0.09 per share, compared to a loss of $11.38 million or $0.20 per share in the same period last year. The company noted that the second-quarter net loss included revenue of $1.71 million related to the agreement with EMD Serono. Excluding the item, adjusted net loss amounted to $7.14 million, down 37.3% from last year. Consolidated revenues for the quarter were $2.31 million, compared to $0.71 million in the previous year period. Theratechnologies
shares T.TH are trading down $0.03 at $2.25.
